Primärer Endpunkt verfehlt: COVID-19: Tocilizumab scheitert in Phase III
Tocilizumab: Rheumamedikament senkt Corona-Sterblichkeit - WELT
CHMP backs expanded approval of tocilizumab | MDedge Hematology and Oncology
WHO Urges Covid-19 Treatment With Roche and Sanofi Anti-Inflammatory Drugs - WSJ
Patientenbroschüre für Erwachsene
Genentech's arthritis drug tocilizumab shows promise in Covid-19 trial
RoActemra® 162 mg 12 St mit dem E-Rezept kaufen - SHOP APOTHEKE
Tocilizumab erhält Zulassungsempfehlung | Gelbe Liste
Rote-Hand-Brief zu RoActemra® (Tocilizumab)
Delhi HC Issues Order on Tocilizumab Shortage, Seeks Patent Working Information from Roche – SpicyIP
Tocilizumab bei schwerem Covid-19 zugelassen
Roche | Actemra
Roche warns of shortage of Covid-19 drug tocilizumab - The Hindu BusinessLine
Approval lapsed) RoActemra tocilizumab 200 mg/ 10mL concentrate for solution for infusion (Roche Germany) | Therapeutic Goods Administration (TGA)
Roche: Priority Review für Actemra/RoActemra | APOTHEKE ADHOC
/cloudfront-us-east-2.images.arcpublishing.com/reuters/QFWUTH5BLZN5LGWVT27LGWPZBE.jpg "Roche arthritis drug reduces COVID-19 deaths in trial in hospitalised patients | Reuters")
Roche arthritis drug reduces COVID-19 deaths in trial in hospitalised patients | Reuters
Tocilizumab erhält Zulassungsempfehlung | Gelbe Liste
Roche gives Tocilizumab worth over Rs 40 crores to MoHFW - Express Pharma
RoActemra® 20 mg/ml 1 St mit dem E-Rezept kaufen - SHOP APOTHEKE
Roche Holding – Wikipedia
Notfallzulassung für Tocilizumab bei Covid-19
FDA approves drug to treat CRS induced by CAR T-cell therapy | MDedge Hematology and Oncology
Tocilizumab Injection Supply: Delhi HC asks Centre to hold meeting with Roche to ensure immediate supply of Tocilizumab - The Economic Times
